We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 147 results

  1. Effects of CYP2D6 and CYP2C19 genetic polymorphisms and cigarette smoking on the pharmacokinetics of tolperisone

    Tolperisone, a muscle relaxant used for post-stroke spasticity, is metabolized to its main metabolite by CYP2D6 and to a lesser extent by CYP2C19 and...

    Ji-Young Byeon, Chang‑Keun Cho, ... Yun Jeong Lee in Archives of Pharmacal Research
    Article 01 August 2023

  2. Effects of CYP2D6*10 allele on the pharmacokinetics of tolperisone

    Tolperisone, a muscle relaxant used for post-stroke spasticity, has been reported to have a very wide interindividual pharmacokinetic variability. It...

    Chang‑Keun Cho, Ji-Young Byeon, ... Yun Jeong Lee in Archives of Pharmacal Research
    Article 21 December 2022

  3. Effects of CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy subjects

    Tolperisone hydrochloride is a centrally-acting muscle relaxant used for relieving spasticities of neurological origin and muscle spasms associated...

    Chang‑Keun Cho, Ji-Young Byeon, ... Yun Jeong Lee in Archives of Pharmacal Research
    Article 23 December 2022

  4. Tolperisone

    in Reactions Weekly
    Article 13 April 2024

  6. NMR study of the inclusion complexes of β-cyclodextrin with diphenhydramine, clonidine and tolperisone

    Abstract

    Forming complexes with β-cyclodextrin can enhance stability, dissolution rate, solubility, and bioavailability of an active pharmaceutical...

    Symbat Zhumakova, Assel Ten, ... Alexey Zazybin in SN Applied Sciences
    Article Open access 08 February 2022

  7. Application of Photogenerated Iodine for Tolperisone Hydrochloride Determination in Tablet Dosage Form

    A technique for accelerated tolperisone hydrochloride (TH) determination in tablet dosage form based on titration of the analytical form with a...

    E. V. Turusova, O. E. Nasakin in Pharmaceutical Chemistry Journal
    Article 01 December 2023

  8. Screen-printed sensors for efficient potentiometric analysis of tolperisone hydrochloride in presence of its co-formulated drugs

    Researchers seeking for green chemistry to help safeguard and boost the economy and the environment by discovering unique ways to decrease waste and...

    Mohamed Rizk, Emad M. Hussein, ... Marwa I. Helmy in BMC Chemistry
    Article Open access 07 November 2022

  9. Tolperisone

    in Reactions Weekly
    Article 22 August 2020

  10. Oral Spasmolytics

    This chapter discusses the various oral medications used and studied for the treatment of spasticity. The more common oral medications currently used...
    Elaine Magat, Isaac Hernandez Jimenez, ... Gerard E. Francisco in Spasticity and Muscle Stiffness
    Chapter 2022

  11. Clinical Problems of Drugs Used to Treat Movement Disorders

    The term movement disorders describes neurological conditions producing abnormalities of movements. They are associated with the basal ganglia and...
    Dirk Dressler, Lizhen Pan in NeuroPsychopharmacotherapy
    Living reference work entry 2022

  12. Clinical Problems of Drugs Used to Treat Movement Disorders

    The term movement disorders describes neurological conditions producing abnormalities of movements. They are associated with the basal ganglia and...
    Dirk Dressler, Lizhen Pan in NeuroPsychopharmacotherapy
    Reference work entry 2022

  13. Tolperisone, a centrally-acting muscle relaxant: a possible cause of macular haemorrhage

    Georgios Tsokolas, Hussein Almuhtaseb, ... Andrew Lotery in Eye
    Article 16 September 2019

  14. Deuterated Drugs

    A deuterated drug comprises diminutive molecules in which deuterium replaces one or more than one hydrogen atoms of the molecule. As deuterium and...

    Nutan Rao, Riddhi Kini, Priyanka Kad in Pharmaceutical Chemistry Journal
    Article 04 March 2022

  15. Multiple drugs

    in Reactions Weekly
    Article 01 June 2024

  16. Therapeutic effects of eperisone on pulmonary fibrosis via preferential suppression of fibroblast activity

    Although the exact pathogenesis of idiopathic pulmonary fibrosis (IPF) is still unknown, the transdifferentiation of fibroblasts into myofibroblasts...

    Ken-ichiro Tanaka, Mikako Shimoda, ... Tohru Mizushima in Cell Death Discovery
    Article Open access 08 February 2022

  17. Nonsurgical Treatment of Discogenic Sciatica

    Conservative (nonsurgical) management is typically the first-line therapeutic intervention in the majority of patients with discogenic sciatica as...
    Ali Akhaddar in Atlas of Sciatica
    Chapter 2023

  18. Faster and Dirtier for Russia: The Story of Yuliya Stepanova

    Yuliya Stepanova (née Rusanova) is a former international 800 m track runner for Russia, who competed in multiple world-level competitions. During...
    Yuliya Stepanova (née Rusanova) in Emerging Drugs in Sport
    Chapter 2022

  19. CDCDB: A large and continuously updated drug combination database

    In recent years, due to the complementary action of drug combinations over mono-therapy, the multiple-drugs for multiple-targets paradigm has...

    Guy Shtar, Louise Azulay, ... Bracha Shapira in Scientific Data
    Article Open access 02 June 2022

  20. “Platelet-Rich Plasma” epidural injection an emerging strategy in lumbar disc herniation: a Randomized Controlled Trial

    Background

    Lumbar herniated disc (HNP) is mainly treated by conservative management. Epidural steroid injection (ESI) has been an option to treat...

    Asarn Wongjarupong, Saran Pairuchvej, ... Pongsthorn Chanplakorn in BMC Musculoskeletal Disorders
    Article Open access 28 April 2023
Did you find what you were looking for? Share feedback.